triggers to initiate androgen-deprivation therapy (adt) in prostate cancer
Published 7 years ago • 3.6K plays • Length 12:11Download video MP4
Download video MP3
Similar videos
-
6:40
considerations for initiating adt in prostate cancer
-
6:14
intermittent versus continuous androgen-deprivation therapy in prostate cancer
-
4:09
intermittent versus continuous androgen deprivation therapy in prostate cancer
-
11:48
localized prostate cancer: androgen deprivation therapy (adt) - 2021 prostate cancer conference
-
17:02
androgen deprivation therapy and prostate cancer
-
4:05
adt and its consequences in the treatment of prostate cancer
-
51:42
2/2/18: androgen deprivation therapy in prostate cancer: adverse effects and strategies to mitigate
-
31:24
optimizing androgen deprivation therapy (adt) in advanced prostate cancer
-
6:15
androgen deprivation therapy for prostate cancer: involving primary care
-
5:59
challenges associated with adt for prostate cancer
-
7:25
optimizing androgen deprivation therapy in high-risk prostate cancer
-
1:37
dr. james mohler discusses androgen-deprivation therapy for prostate cancer
-
6:24
age, exercise, and adt for prostate cancer
-
1:24
dr. tward on abbreviated course adt for prostate cancer
-
1:07
dr. abdenour nabid on shorter duration of adt in prostate cancer
-
1:25
dr. mohler on overuse of adt in prostate cancer and nccn guidelines
-
5:30
zuclomiphene citrate: overcoming the estrogenic side effects of adt in mcrpc patients
-
4:43
adt as treatment in metastatic prostate cancer
-
2:00
improving androgen-deprivation therapy for prostate cancer